Referred to the House Committee on Energy and Commerce.
The Tick Identification Pilot Program Act of 2025 authorizes the Secretary of Health and Human Services, through CDC, to award grants to states to implement tick identification programs. Funded state programs must accept electronic photo submissions of ticks (with date, likely geographic and physical location), have a qualified professional review submissions, and respond to individuals within 72 hours with species/life-stage identification (if possible), a risk estimate for tick-borne disease, recommendations for care and testing, and prevention education.
Funding and appropriations: liberals and centrists want clear funding; conservatives worry about open-ended federal spending.
Relative to its intended legislative type, this bill establishes a narrowly scoped federal grant pilot with concrete program features and reporting requirements but omits several implementation-critical elements such as funding authorizations, privacy protections, award/selection detail, and safeguards against misuse.
The Tick Identification Pilot Program Act of 2025 authorizes the Secretary of Health and Human Services, through CDC, to award grants to states to implement tick identification programs.
Funded state programs must accept electronic photo submissions of ticks (with date, likely geographic and physical location), have a qualified professional review submissions, and respond to individuals within 72 hours with species/life-stage identification (if possible), a risk estimate for tick-borne disease, recommendations for care and testing, and prevention education.
Funded programs must maintain a database of reported incidents and related information, and the Secretary must collect standardized data from each funded state and submit annual reports to Congress for fiscal years 2026–2029.
Content-wise the bill is narrow, technical, and non-controversial—factors that favor enactment—but its lack of an authorized funding amount, the need for committee and floor time, and typical legislative congestion reduce its standalone odds. Such pilot grant bills commonly succeed when paired with an appropriations vehicle or bundled into larger bipartisan health legislation; alone, many similar bills stall in committee.
Relative to its intended legislative type, this bill establishes a narrowly scoped federal grant pilot with concrete program features and reporting requirements but omits several implementation-critical elements such as funding authorizations, privacy protections, award/selection detail, and safeguards against misuse.
Funding and appropriations: liberals and centrists want clear funding; conservatives worry about open-ended federal spending.
These are examples from the analysis, not a ranked list of the most-affected groups.
Funding and appropriations: liberals and centrists want clear funding; conservatives worry about open-ended federal spending.
This persona would likely view the bill positively as a targeted public-health intervention that improves surveillance, early identification, and public education around tick-borne diseases.
They would see it as a preventive measure that could reduce morbidity from Lyme and other diseases and produce data useful for research and environmental health planning.
They would note the program’s emphasis on rapid response and public outreach as strengths, while wanting assurances on equitable access and privacy protections.
This persona would view the bill as a pragmatic, narrowly targeted public-health pilot that could fill gaps in tick surveillance and citizen guidance.
They would appreciate the grant-to-state approach and data-reporting requirements but would be concerned about implementation details—particularly funding, administrative burden, and the feasibility of a 72-hour professional response standard.
They would seek cost-benefit information and guardrails on privacy and duplication with existing programs before fully endorsing expansion beyond a pilot.
This persona would be cautiously receptive to a narrowly focused, state-driven pilot that addresses a concrete public-health problem, but they would be wary of expanding federal programs, undefined spending, and creation of federal databases.
They would emphasize state control, fiscal restraint, privacy safeguards, and limiting federal intrusion.
Support would hinge on assurances that the program is modest in cost, voluntary for states, and respects data privacy and state authority.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content-wise the bill is narrow, technical, and non-controversial—factors that favor enactment—but its lack of an authorized funding amount, the need for committee and floor time, and typical legislative congestion reduce its standalone odds. Such pilot grant bills commonly succeed when paired with an appropriations vehicle or bundled into larger bipartisan health legislation; alone, many similar bills stall in committee.
The bill has not accumulated any surfaced votes yet.
Funding and appropriations: liberals and centrists want clear funding; conservatives worry about open-ended federal spending.
Content-wise the bill is narrow, technical, and non-controversial—factors that favor enactment—but its lack of an authorized funding amount…
Relative to its intended legislative type, this bill establishes a narrowly scoped federal grant pilot with concrete program features and reporting requirements but omits several implementation-critical elements such as…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.